At least five companies reported earnings last week. MorphoSys AG (Xetra:MOR; Pink:MPSYF) and Santarus Inc. (NASDAQ:SNTS) were up more than 10% on the week. MorphoSys, which provides antibody services and develops antibody drug candidates, swung to a net profit in 4Q12 on a 34% jump in revenues to €16.5 million ($21.8 million), while specialty pharma Santarus outpaced the Street's revenue and earnings expectations. Merck KGaA (Xetra:MRK) added $1.3 billion in market cap last week after reporting 4Q12 earnings and revenues that beat the Street's estimates. Mcap in $M


4Q12 EPS est

4Q12 EPS actual


Growth From 4Q11

3/8 cls

Wk chg

% chg

Mcap chg

3/8 Mcap

Merck KGaA (Xetra:MRK)



Beat by €0.02